Will Research Rules Under MiFID II Prevent Small And Medium Sized Companies From Raising Capital?

MG
Maples Group

Contributor

The Maples Group is a leading service provider offering clients a comprehensive range of legal services on the laws of the British Virgin Islands, the Cayman Islands, Ireland, Jersey and Luxembourg, and is an independent provider of fiduciary, fund services, regulatory and compliance, and entity formation and management services.
One of the unintended consequences of MiFID II is the cooling effect unbundling of research from dealing commission is likely to have on small and medium size companies.
Ireland Finance and Banking

One of the unintended consequences of MiFID II is the cooling effect unbundling of research from dealing commission is likely to have on small and medium size companies. By their nature these companies need analysts and research to highlight the opportunity to the buy side and a tightening in research budgets is likely to have a disproportionate impact on them, restricting the potential for small and medium sized companies to raise capital, which can only have negative consequences for the European economy. The below clarification from the FCA although limited in scope should be welcomed and I hope this interpretation will also be adopted by the CBI and ESMA as it relates to Irish MiFID firms.


Analysts and small companies are breathing a sigh of relief. The Financial Conduct Authority has decided that a free research report linked to a share issue is not an "inducement" under the terms of Mifid II, the European Union's new financial regulation.

https://www.ft.com/content/f183933c-626a-11e7-91a7-502f7ee26895 (Subscription required)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More